Clinical features of immune checkpoint inhibitor-related pneumonitis in older patients with lung cancer receiving immune checkpoint inhibitors-based therapy: a retrospective study
Abstract Background Older patients with lung cancer are underrepresented in pivotal trials of immune checkpoint inhibitors (ICIs). This study primarily retrospectively evaluated the older patients with lung cancer treated with ICIs to determine which factors are related to the occurrence and prognos...
Saved in:
| Main Authors: | Jiafan Liu, Dongmei Zhou, Na Wu, Jia Liu, Xiaonan Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Geriatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12877-025-05905-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?
by: David Spillane, et al.
Published: (2025-04-01) -
Immune checkpoint inhibitor-related pneumonitis following discontinuation of pembrolizumab in a patient with advanced lung adenocarcinoma: a case report and literature review
by: Huan Wang, et al.
Published: (2024-12-01) -
A Systematic Review of Pneumonitis Following Treatment with Immune Checkpoint Inhibitors and Radiotherapy
by: Melina Yerolatsite, et al.
Published: (2025-04-01) -
Managing Immune Checkpoint Inhibitor Pneumonitis in the ICU
by: Kristina Montemayor, MD, MHS, et al.
Published: (2025-03-01) -
Risk factors for checkpoint inhibitor pneumonitis in lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Xiaoqing Zhou, et al.
Published: (2025-05-01)